Micro Therapeutics Inc.
- Share via
The Irvine manufacturer of medical devices incurred a third-quarter net loss of $3.1 million, or 31 cents a share, compared with a net loss of $2.8 million, or 35 cents a share, for the year-earlier period. Sales rose 57% to $1.4 million, boosted in part by revenue from its neuro vascular product line.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
